Theralase Technologies Inc. (TLT)
TSXV
Closed
Oct 9, 2026
Day's Range
0.175052 wk Range
0.1500Overview - TLT - Theralase Technologies Inc.
Key Statistics
Valuation
Enterprise Value
49.22M
P/E (Trailing)
‪-10.93‬
P/E (Forward)
‪-17.50‬
PEG Ratio
‪-17.50‬
Price / Sales (TTM)
‪67.70‬
Price / Book
‪7.60‬
EV / EBITDA
‪-13.48‬
Profitability
Gross Margin
‪52.07%‬
Profit Margin
‪62.11%‬
Operating Margin
‪-647.23%‬
Return on Assets
‪-42.70%‬
Return on Equity
‪-93.40%‬
Ownership
Shares Outstanding
295.67M
Float
291.32M
Held by Insiders
‪8.44%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.48‬
50-Day Avg
‪0.2050‬
200-Day Avg
‪0.2470‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
1 analysts
Market Cap - TLT - Theralase Technologies Inc.
Peers - TLT - Theralase Technologies Inc.
Peer Comparison
Compared with companies in Medical Devices listed on TSXV.
Profile Summary - TLT - Theralase Technologies Inc.
About
Theralase Technologies Inc. is a prominent player in the medical technology sector, focusing on the design, manufacture, and commercialization of innovative laser technologies. The company's primary purpose is to develop advanced laser systems for therapeutic medical treatments, particularly in the fields of oncology…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
